1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
78.38%
Revenue growth above 1.5x WEED.TO's 38.52%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
140.18%
Gross profit growth above 1.5x WEED.TO's 28.16%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
12.00%
EBIT growth 50-75% of WEED.TO's 18.21%. Martin Whitman would suspect suboptimal resource allocation.
12.00%
Operating income growth at 50-75% of WEED.TO's 18.21%. Martin Whitman would doubt the firm’s ability to compete efficiently.
14.27%
Net income growth at 50-75% of WEED.TO's 22.90%. Martin Whitman would question fundamental disadvantages in expenses or demand.
13.68%
EPS growth at 50-75% of WEED.TO's 25.59%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
13.68%
Diluted EPS growth at 50-75% of WEED.TO's 22.87%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.10%
Positive OCF growth while WEED.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-23.74%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-428.58%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-428.58%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-428.58%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-115.04%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-115.04%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-115.04%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
123.15%
10Y equity/share CAGR in line with WEED.TO's 119.92%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
123.15%
5Y equity/share CAGR is in line with WEED.TO's 129.43%. Walter Schloss would see parallel mid-term profitability and retention policies.
123.15%
3Y equity/share CAGR at 75-90% of WEED.TO's 156.94%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.45%
AR growth well above WEED.TO's 27.03%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.96%
Inventory growth well above WEED.TO's 9.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.73%
Negative asset growth while WEED.TO invests at 6.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.17%
We have a declining book value while WEED.TO shows 3.19%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.27%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.